About: We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?
Creator	Kersten, Daniel Makaryus, Amgad
Source	Medline; PMC
abstract	covid:4ae7d0f44971b45c7735e3d4d0487bccf74fedc6#abstract
has issue date	2020-07-01(xsd:dateTime)
bibo:doi	10.1089/heq.2020.0019
bibo:pmid	32760874
has license	cc-by
sha1sum (hex)	4ae7d0f44971b45c7735e3d4d0487bccf74fedc6
schema:url	https://doi.org/10.1089/heq.2020.0019
resource representing a document's title	We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?
has PubMed Central identifier	PMC7398429
has PubMed identifier	32760874
schema:publication	Health Equity
resource representing a document's body	covid:4ae7d0f44971b45c7735e3d4d0487bccf74fedc6#body_text
is schema:about of	named entity 'COVID-19' named entity 'socioeconomic status' named entity 'supply chain' named entity 'supply chain' named entity 'health insurance' named entity 'limited resource' named entity 'urban environments' named entity 'U.S.' named entity 'COVID' named entity 'public hospitals' named entity 'medical care' named entity 'medical products' named entity 'virus' named entity 'federal government' named entity 'pharmaceutical agents' named entity 'poor urban areas' named entity 'uninsured patients' named entity 'urban poverty' named entity 'medical care' named entity 'COVID' named entity 'COVID-19' named entity 'medication compliance' named entity 'COVID-19 pandemic' named entity 'pharmacies' named entity 'health insurance' named entity 'coronavirus disease 2019' named entity 'pharmacies' named entity 'health professional shortage areas' named entity 'socioeconomic status' named entity 'urban poverty' named entity 'socioeconomic status' named entity 'medical professionals' named entity 'urban centers' named entity 'pharmacies' named entity 'chronic illnesses' named entity 'critically ill patients' named entity 'medical care' named entity 'pharmacy' named entity 'virus' named entity 'pharmacy' named entity 'lower income' named entity 'socioeconomic status' named entity 'U.S. Food and Drug Administration' named entity 'urban areas' named entity 'U.S.' named entity 'United States' named entity 'urban areas' named entity 'unemployment' named entity 'pharmaceutical' named entity 'pharmacies' named entity 'COVID-19' named entity 'Develop' named entity 'May' named entity 'Them' named entity 'Medications' named entity 'Can We' named entity 'EFFECTIVE' named entity 'BUT' named entity 'COVID-19' named entity 'DISTRIBUTE' named entity 'MEDICATIONS'
is part of of	covid:4ae7d0f44971b45c7735e3d4d0487bccf74fedc6#abstract covid:4ae7d0f44971b45c7735e3d4d0487bccf74fedc6#body_text We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software